Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis
Authors:
- S WardSWS Ward
- A ScopeASA Scope
- R RafiaRRR Rafia
- A PandorAPA Pandor
- S HarnanSHS Harnan
- P EvansPEP Evans
- L WyldLWL Wyld
Open Access
- 1 October 2013
- journal article
- review article
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 17 (44) , 1-+
Abstract
Health Technology Assessment Volume: 17, Issue: 44, Published in October 2013Keywords
Funding Information
- National Institute for Health Research
This publication has 128 references indexed in Scilit:
- Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor‐positive, HER2‐normal, grade II, lymph node‐negative breast cancersCancer, 2010
- Use of a genomic test (MammaPrint™) in daily clinical practice to assist in risk stratification of young breast cancer patientsArchives of Gynecology and Obstetrics, 2010
- Clinical significance of the 21‐gene signature (Oncotype DX) in hormone receptor‐positive early stage primary breast cancer in the Japanese populationCancer, 2010
- Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancerJournal of Cancer Research and Clinical Oncology, 2009
- The influence of a Gene expression profile on breast cancer decisionsJournal of Surgical Oncology, 2009
- The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate modelBreast Cancer Research and Treatment, 2009
- Validation of 70-gene prognosis signature in node-negative breast cancerBreast Cancer Research and Treatment, 2008
- The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation studyBreast Cancer Research and Treatment, 2008
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateCancer, 1983